Key facts
- Dendritic Health AI’s last known valuation is $9.0M (Apr 2026).
- It has raised $770K; the latest was Seed Round ($440K) in Apr 2026.
- Notable investors include Rice Alliance for Technology and Entrepreneurship, Vaark Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Dendritic Health AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Dendritic Health AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dendritic Health AI
Developer of education tools intended to serve healthcare professionals. The company's software helps medical students and professionals with medical searches, practice questions, clinical simulation, and flashcard generation, enabling healthcare institutes to improve the medical training process.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2023
- Employees
- 5
- Website
- dendritichealth.com/
- Ownership
- Privately Held (backing)
Dendritic Health AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dendritic Health AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dendritic Health AI in its N-PORT filings yet. We sweep new filings monthly.